Trial intelligence / Profile preview

Dexmedetomidine vs Nerve Block for Awake Fiberoptic Intubation

NCT06651905Completed

Sponsor
Cairo University
Start
Jan 2024
Primary completion
Sep 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of dexmedetomidine (2 arms), sponsored by Cairo University. Primary endpoint: Intubation score at 10 minutes. Started Jan 2024; status: completed.

02

Drugs

dexmedetomidine

Beyond the preview

Go deeper on NCT06651905.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06651905.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call